Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) last issued its quarterly earnings data on Tuesday, May 12th. Verrica Pharmaceuticals had a negative net margin of 47.97% and a negative return on equity of 1,077.78%. Get Verrica Pharmaceuticals alerts:Verrica Pharmaceuticals Trading Up 3.4%NASDAQ VRCA traded up $0.18 on Tuesday, hitting $5.43. Verrica Pharmaceuticals Company Profile(Get Free Report)Verrica Pharmaceuticals Inc is a clinical‐stage biopharmaceutical company focused on the development and commercialization of topical therapies for dermatological conditions. See AlsoReceive News & Ratings for Verrica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verrica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.